Christian Marth, MD, PhD, discusses the differences between mismatch repair–deficient and –proficient subtypes of advanced/recurrent endometrial cancer and other research efforts of interest.
FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
ChatGPT Displays Potential for Genetic Counseling in Gynecologic Oncology
Naumann Discusses Notable Research Efforts in Endometrial Cancer
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
Sinno Spotlights Key Clinical Trials Driving Targeted Approaches in Gynecologic Oncology
TAR-200 Leads to Durable Responses in Bacillus Calmette–Guérin-Unresponsive NMIBC
HIFU Proves Noninferior to Radical Prostatectomy in Localized Prostate Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority